Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Mainz Biomed N.V. (MYNZ)

Mainz Biomed N.V. (MYNZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Financial Summary for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Mainz Biomed N.V. develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The Company's flagship product is ColoAlert, an accurate, non-invasive, and easy-to-use early detection diagnostic test for colorectal cancer. Mainz Biomed N.V. is based in BERKELEY, Calif.

Fiscal Year End Date: 12/31

Income Statement

(Values in U.S. Thousands) Dec, 2023 Sep, 2023 Jun, 2023 Mar, 2023 Sep, 2022
Sales 210 180 250 250 100
Sales Growth +16.67% -28.00% unch +150.00% unch
Net Income -5,180 -6,300 -8,250 -6,560 -5,600
Net Income Growth +17.78% +23.64% -25.76% -17.14% +1.06%

Balance Sheet

(Values in U.S. Thousands) Dec, 2023 Sep, 2023 Jun, 2023 Mar, 2023 Sep, 2022
Total Assets 9,800 13,240 8,450 15,410 17,910
Total Assets Growth -25.98% +56.69% -45.17% -13.96% -7.25%
Total Liabilities 7,280 7,190 12,590 12,160 14,460
Total Liabilities Growth +1.25% -42.89% +3.54% -15.91% +2.34%

Cash Flow

(Values in U.S. Thousands) Dec, 2023 Sep, 2023 Jun, 2023 Mar, 2023 Sep, 2022
Operating Cash Flow -6,520 -17,090 -8,150 -21,940 -17,280
Operating Cash Flow Growth +61.85% -109.69% +62.85% -26.97% -60.30%
Net Cash Flow -4,320 -840 -6,090 -10,070 -7,820
Change in Net Cash Flow -414.29% +86.21% +39.52% -28.77% -25.52%
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot